(Q39469516)

12 September 2017

1 reference

title

The functional importance of beta 1 and beta 2 adrenoceptors in the human heart (English)

1 reference

12 September 2017

Brodde OE

1

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 August 1988

1 reference

American Journal of Cardiology

12 September 2017

published in

1 reference

12 September 2017

volume

62

1 reference

12 September 2017

issue

5

1 reference

12 September 2017

page(s)

24C-29C

1 reference

Differentiation of Receptor Systems activated by Sympathomimetic Amines

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980063-8

Beta-adrenergic receptors: biochemical mechanisms of physiological regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980063-8

Cardiac effects of beta-adrenergic receptor antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980063-8

The affinity of (-)-propranolol for beta 1- and beta 2-adrenoceptors of human heart. Differential antagonism of the positive inotropic effects and adenylate cyclase stimulation by (-)-noradrenaline and (-)-adrenaline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980063-8

Beta 2-adrenoceptor-mediated positive inotropic effect of adrenaline in human ventricular myocardium. Quantitative discrepancies with binding and adenylate cyclase stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980063-8

The role of cyclic AMP in the positive inotropic effect mediated by beta 1- and beta 2-adrenoceptors in isolated human right atrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980063-8

Some Aspects of the Biological Role of Adenosine 3',5'-monophosphate (Cyclic AMP)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980063-8

Human myocardial beta-adrenoceptors: demonstration of both beta 1- and beta 2-adrenoceptors mediating contractile responses to beta-agonists on the isolated right atrium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980063-8

Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980063-8

Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980063-8

In support of cardiac chronotropic beta 2 adrenoceptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980063-8

Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980063-8

Is beta 1-antagonism essential for the antihypertensive action of beta-blockers?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980063-8

Observations on the mechanism underlying the differences in exercise and isoprenaline tachycardia after cardioselective and non-selective beta-adrenoceptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980063-8

Beta-adrenergic function in heart muscle disease and heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980063-8

The autonomic nervous system in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980063-8

Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980063-8

Haemodynamic, metabolic, and lymphocyte beta 2-adrenoceptor changes following chronic beta-adrenoceptor antagonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980063-8

Beta-adrenoceptor antagonists (non-selective as well as beta 1-selective) with partial agonistic activity decrease beta 2-adrenoceptor density in human lymphocytes. Evidence for a beta 2-agonistic component of the partial agonistic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980063-8

Identification of solubilised beta1 and beta2 adrenoceptors in mammalian lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980063-8

Human cardiac beta-adrenergic receptors: Subtype heterogeneity delineated by direct radioligand binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980063-8

Coexistence of beta 1- and beta 2-adrenoceptors in human right atrium. Direct identification by (+/-)-[125I]iodocyanopindolol binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980063-8

Beta-adrenoceptor density and relative number of beta-adrenoceptor subtypes in biopsies from human right atrial, left ventricular, and right ventricular myocard

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980063-8

Selective regulation of beta 1- and beta 2-adrenoceptors in the human heart by chronic beta-adrenoceptor antagonist treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980063-8

Characterization and autoradiographic localization of beta-adrenoceptor subtypes in human cardiac tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980063-8

10.1016/S0002-9149(88)80063-8

7 January 2021

Identifiers

DOI

1 reference

12 September 2017

1 reference